OC
CLMT icon

Oppenheimer & Co’s Calumet Specialty Products CLMT Stock Holding History

Oppenheimer & Co’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,695
Closed -$138K – 1244
2016
Q1 		$138K Buy
+11,695
New +$163K ﹤0.01% 1157
2014
Q3 		– Sell
-8,812
Closed -$280K – 1434
2014
Q2 		$280K Sell
8,812
-3,559
-29% -$106K 0.01% 1087
2014
Q1 		$320K Buy
12,371
+40
+0.3% +$1.09K 0.01% 1017
2013
Q4 		$321K Sell
12,331
-9,431
-43% -$264K 0.01% 982
2013
Q3 		$594K Sell
21,762
-447
-2% -$14K 0.02% 713
2013
Q2 		$808K Buy
+22,209
New +$798K 0.03% 574

Other funds holding CLMT

RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
SOAMC
Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Oppenheimer & Co's CLMT Position: Q2 2016 in Review

Oppenheimer & Co sold out of Calumet Specialty Products (CLMT) in Q2 2016, closing a stake of 11,695 shares — an estimated $138K sold.

Oppenheimer & Co first reported a position in CLMT in Q2 2013 and held it in 6 quarters. The position peaked at $808K in Q2 2013. 90 funds tracked by Wall St. Rank hold CLMT as of Q2 2016.

  • Oppenheimer & Co reported no remaining Calumet Specialty Products position as of Q2 2016 after selling out during the quarter.
  • Oppenheimer & Co sold 11,695 Calumet Specialty Products shares in Q2 2016, an estimated $138K.
  • Oppenheimer & Co first reported a position in Calumet Specialty Products in Q2 2013 and held it in 6 quarters.
  • Oppenheimer & Co's Calumet Specialty Products position peaked at $808K in Q2 2013.
  • 90 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2016.

Based on Oppenheimer & Co's 13F filing for Q2 2016, filed 8 Aug 2016.